Analyzing and prioritizing service lines like a portfolio can support focused growth, even during a financial crisis. Cost cutting is critical but insufficient to ensure viability and success when the financial crisis faced by health systems is prolonged, as it has been in 2022. Health systems must also grow revenue. Tight budgets and limited access […]
Amazon made a major move into healthcare in July when it announced plans to buy One Medical in a $3.9 billion deal. Suddenly, theoretical discussions about the future of healthcare—a future that could be dominated by tech giants such as Amazon, Google and Apple—came into sharp focus as the potential for Amazon to reinvent primary […]
This clinically integrated network (“CIN”) had a track record of success, but was still leaving money on the table. Did they need to achieve formal CIN designation? Would one model of physician participation accommodate all types of interested physicians? Contact our Thought Leaders: John Harris, Managing Director, jharris@veralon.com Molly Johnson, Consultant, mjohnson@veralon.com
Challenge: Design a strategy to become the market leader for oncology services across a broad region that accounted for implications of emerging trends specific to: incidence of tumor sites, population, evolution of care, competitor vulnerabilities, and oncology reimbursement. Contact our Thought Leader: Mark Dubow, Director, mdubow@veralon.com
Health systems and their Clinically Integrated Networks (CINs) face threats from a variety of competitors, including market disruptors, that may lure away aligned independent physicians and patients. Although the landscape of these competitors differs by market, they threaten the core business of CINs and complicate health system alignment with independent physician groups. Contact the Author: […]
As health system physician enterprises have grown, addressing their challenges are central to health system success. Engaging physicians and supporting health system goals requires a cohesive approach. Contact the Experts: Mark Dubow, Director, mdubow@veralon.com Rudd Kierstead, Principal, rkierstead@veralon.com
Do you have a CIN? Is it achieving what it should? Contact the Authors: John Harris, Managing Director, jharris@veralon.com Molly Johnson, Manager, mjohnson@veralon.com
Shifting a $1 trillion dollar industry from confidential contracts to publicly published pricing is a massive transformation. In the middle of recovering from the COVID-19 crisis, hospitals are responding to this transformation. Background: The hospital price transparency rules require consumer-friendly tools to help individuals shop for hospital services based on price. They also require hospitals […]
By recategorizing procedures previously designated inpatient only, CMS is actively redirecting a significant number of cases to Hospital Outpatient Department (“HOPD”) and community-based ambulatory surgery center (“ASC”) settings. We have discussed the impact this will have on outpatient surgery, and strategies to prepare. This outpatient shift will also affect cardiac services, creating both risks and […]
Rapid evolution in diagnostics and treatment for cancer care, innovation through genomics and predictive analytics, the continuing shift toward value-based care are hastening the migration of oncology from hospital settings to community-based centers. This raises the question: Is now the right time to invest in a community oncology center? The experiences of multiple health systems […]